NOD2 is involved in the inflammatory response after cerebral ischemia-reperfusion injury and triggers NADPH oxidase 2-derived reactive oxygen species

International Journal of Biological Sciences

Volumn 11, Issue 5, 2015, Pages 525-535

  Liu, Huiqing ^a   Wei, Xinbing ^a   Kong, Lingjun ^a   Liu, Xiaoqian ^a,b   Cheng, Li ^a   Yan, Shi ^c   Zhang, Xiumei ^a   Chen, Lin ^a  

^a SHANDONG UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Cerebral ischemia reperfusion; Inflammation; MAPK; NADPH oxidase; NF B; Nucleotide binding oligomerization domain (NOD)2

Indexed keywords

MUS;

CARD15 PROTEIN, MOUSE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYBB PROTEIN, MOUSE; MEMBRANE PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL; BRAIN ISCHEMIA; C57BL MOUSE; GENE EXPRESSION REGULATION; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; REPERFUSION INJURY; UPREGULATION;

ANIMALS; BRAIN ISCHEMIA; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INFLAMMATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NADPH OXIDASE; NOD2 SIGNALING ADAPTOR PROTEIN; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY; UP-REGULATION;

EID: 84928796762     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.10927     Document Type: Article

References (39)

1. Poisson SN, Schardt TQ, Dingman A, Bernard TJ. Etiology and treatment of arterial ischemic stroke in children and young adults. Current treatment options in neurology. 2014; 16: 315. doi:10.1007/s11940-014-0315-4
2. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Current opinion in neurology. 2007; 20: 334-42. doi:10.1097/WCO.0b013e32813ba151
3. Amantea D, Nappi G, Bernardi G, Bagetta G, Corasaniti MT. Post-ischemic brain damage: pathophysiology and role of inflammatory mediators. The FEBS journal. 2009; 276: 13-26. doi:10.1111/j.1742-4658.2008.06766.x
4. Nguyen MD, Julien JP, Rivest S. Innate immunity: the missing link in neuroprotection and neurodegeneration? Nature reviews Neuroscience. 2002; 3: 216-27. doi:10.1038/nrn752
5. Kim JY, Kawabori M, Yenari MA. Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets. Current medicinal chemistry. 2014; 21: 2076-97
6. Inohara, Chamaillard, McDonald C, Nunez G. NOD-LRR proteins: role in host-microbial interactions and inflammatory disease. Annual review of biochemistry. 2005; 74: 355-83. doi:10.1146/annurev.biochem.74.082803.133347
7. Wilmanski JM, Petnicki-Ocwieja T, Kobayashi KS. NLR proteins: integral members of innate immunity and mediators of inflammatory diseases. Journal of leukocyte biology. 2008; 83: 13-30. doi:10.1189/jlb.0607402
8. Abulafia DP, de Rivero Vaccari JP, Lozano JD, Lotocki G, Keane RW, Dietrich WD. Inhibition of the inflammasome complex reduces the inflammatory response after thromboembolic stroke in mice. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2009; 29: 534-44. doi:10.1038/jcbfm.2008.143
9. Yang F, Wang Z, Wei X, Han H, Meng X, Zhang Y, et al. NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2014. doi:10.1038/jcbfm.2013.242
10. Kufer TA. Signal transduction pathways used by NLR-type innate immune receptors. Molecular bioSystems. 2008; 4: 380-6. doi:10.1039/b718948f
11. Ting JP, Duncan JA, Lei Y. How the noninflammasome NLRs function in the innate immune system. Science. 2010; 327: 286-90. doi:10.1126/science.1184004
12. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 2001; 411: 603-6. doi:10.1038/35079114
13. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001; 411: 599-603. doi:10.1038/35079107
14. Liu HQ, Zhang XY, Edfeldt K, Nijhuis MO, Idborg H, Back M, et al. NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis. Arteriosclerosis, thrombosis, and vascular biology. 2013; 33: 2193-201. doi:10.1161/ATVBAHA.113.301715
15. Sterka D, Jr., Marriott I. Characterization of nucleotide-binding oligomerization domain (NOD) protein expression in primary murine microglia. Journal of neuroimmunology. 2006; 179: 65-75. doi:10.1016/j.jneuroim.2006.06.009
16. Sterka D, Jr., Rati DM, Marriott I. Functional expression of NOD2, a novel pattern recognition receptor for bacterial motifs, in primary murine astrocytes. Glia. 2006; 53: 322-30. doi:10.1002/glia.20286
17. Chauhan VS, Sterka DG, Jr., Furr SR, Young AB, Marriott I. NOD2 plays an important role in the inflammatory responses of microglia and astrocytes to bacterial CNS pathogens. Glia. 2009; 57: 414-23. doi:10.1002/glia.20770
18. Jasmin JF, Malhotra S, Singh Dhallu M, Mercier I, Rosenbaum DM, Lisanti MP. Caveolin-1 deficiency increases cerebral ischemic injury. Circulation research. 2007; 100: 721-9. doi:10.1161/01.RES.0000260180.42709.29
19. Mocco J, Mack WJ, Ducruet AF, Sosunov SA, Sughrue ME, Hassid BG, et al. Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circulation research. 2006; 99: 209-17. doi:10.1161/01.RES.0000232544.90675.42
20. Yi F, Zhang AY, Janscha JL, Li PL, Zou AP. Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney international. 2004; 66: 1977-87. doi:10.1111/j.1523-1755.2004.00968.x
21. del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain pathology. 2000; 10: 95-112
22. Ketelhuth DF, Rios FJ, Wang Y, Liu H, Johansson ME, Fredrikson GN, et al. Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses. Circulation. 2011; 124: 2433-43, 1-7. doi:10.1161/CIRCULATIONAHA.111.051599
23. Liu HQ, Wei XB, Sun R, Cai YW, Lou HY, Wang JW, et al. Angiotensin II stimulates intercellular adhesion molecule-1 via an AT1 receptor/nuclear factor-kappaB pathway in brain microvascular endothelial cells. Life sciences. 2006; 78: 1293-8. doi:10.1016/j.lfs.2005.06.049
24. Ridder DA, Schwaninger M. NF-kappaB signaling in cerebral ischemia. Neuroscience. 2009; 158: 995-1006. doi:10.1016/j.neuroscience.2008.07.007
25. Yang CS, Shin DM, Kim KH, Lee ZW, Lee CH, Park SG, et al. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. Journal of immunology. 2009; 182: 3696-705. doi:10.4049/jimmunol.0802217
26. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nature immunology. 2005; 6: 587-92. doi:10.1038/ni1200
27. Yang CS, Kim JJ, Lee SJ, Hwang JH, Lee CH, Lee MS, et al. TLR3-triggered reactive oxygen species contribute to inflammatory responses by activating signal transducer and activator of transcription-1. Journal of immunology. 2013; 190: 6368-77. doi:10.4049/jimmunol.1202574
28. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. Journal of leukocyte biology. 2010; 87: 779-89. doi:10.1189/jlb.1109766
29. Aloisi F. Immune function of microglia. Glia. 2001; 36: 165-79
30. Farina C, Aloisi F, Meinl E. Astrocytes are active players in cerebral innate immunity. Trends in immunology. 2007; 28: 138-45. doi:10.1016/j.it.2007.01.005
31. Stephenson D, Yin T, Smalstig EB, Hsu MA, Panetta J, Little S, et al. Transcription factor nuclear factor-kappa B is activated in neurons after focal cerebral ischemia. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2000; 20: 592-603. doi:10.1097/00004647-200003000-00017
32. Nozaki K, Nishimura M, Hashimoto N. Mitogen-activated protein kinases and cerebral ischemia. Molecular neurobiology. 2001; 23: 1-19. doi:10.1385/MN:23:1:01
33. Kaminska B. MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. Biochimica et biophysica acta. 2005; 1754: 253-62. doi:10.1016/j.bbapap.2005.08.017
34. Barone FC, Irving EA, Ray AM, Lee JC, Kassis S, Kumar S, et al. Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia. Medicinal research reviews. 2001; 21: 129-45
35. Murata Y, Fujiwara N, Seo JH, Yan F, Liu X, Terasaki Y, et al. Delayed inhibition of c-Jun N-terminal kinase worsens outcomes after focal cerebral ischemia. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2012; 32: 8112-5. doi:10.1523/JNEUROSCI.0219-12.2012
36. Chen H, Song YS, Chan PH. Inhibition of NADPH oxidase is neuroprotective after ischemia-reperfusion. Journal of cerebral blood flow and metabolism: official journal of the International Society of Cerebral Blood Flow and Metabolism. 2009; 29: 1262-72. doi:10.1038/jcbfm.2009.47
37. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, et al. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke; a journal of cerebral circulation. 2007; 38: 3000-6. doi:10.1161/STROKEAHA.107.489765
38. Lam GY, Huang J, Brumell JH. The many roles of NOX2 NADPH oxidase-derived ROS in immunity. Seminars in immunopathology. 2010; 32: 415-30. doi:10.1007/s00281-010-0221-0
39. Lipinski S, Till A, Sina C, Arlt A, Grasberger H, Schreiber S, et al. DUOX2-derived reactive oxygen species are effectors of NOD2-mediated antibacterial responses. Journal of cell science. 2009; 122: 3522-30. doi:10.1242/jcs.050690.